SF4875

Medical cannabis endorsement requirements modification
Legislative Session 94 (2025-2026)

Related bill: HF4412

Bill text

Introduction

ReadChanges
PDF
(underlined = new law, struck through = current law the bill removes)
1.1A bill for an act
1.2relating to cannabis; modifying requirements for the medical cannabis endorsement;
1.3amending Minnesota Statutes 2024, section 342.51, subdivisions 1, 3; Minnesota
1.4Statutes 2025 Supplement, section 342.51, subdivision 2.
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.6Section 1. Minnesota Statutes 2024, section 342.51, subdivision 1, is amended to read:
1.7Subdivision 1. Endorsement; authorized actions. (a) The office may issue a medical
1.8cannabis endorsement to a cannabis business authorizing the business to:
1.9(1) cultivate medical cannabis;
1.10(2) process medical cannabinoid products; or
1.11(3) sell or distribute medical cannabis flower and medical cannabinoid products to any
1.12person authorized to receive medical cannabis flower or medical cannabinoid products.
1.13(b) The office must issue a medical cannabis cultivation endorsement to a cannabis
1.14license holder if the license holder:
1.15(1) is authorized to cultivate cannabis;
1.16(2) submits a medical cannabis endorsement application to the office; and
1.17(3) otherwise meets all applicable requirements established by the office.
1.18(c) A medical cannabis cultivation endorsement entitles the license holder to grow
1.19cannabis plants within the approved amount of space from seed or immature plant to mature
1.20plant, harvest cannabis flower from a mature plant, package and label cannabis flower as
2.1medical cannabis flower, sell medical cannabis flower to cannabis businesses with a medical
2.2cannabis endorsement, and perform other actions approved by the office.
2.3(d) The office must issue a medical cannabis processor endorsement to a cannabis license
2.4holder if the license holder:
2.5(1) is authorized to manufacture cannabis products;
2.6(2) submits a medical cannabis endorsement application to the office; and
2.7(3) otherwise meets all applicable requirements established by the office.
2.8(e) A medical cannabis processor endorsement entitles the license holder to:
2.9(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts,
2.10and hemp concentrate from cannabis businesses with a medical cannabis cultivator
2.11endorsement or a medical cannabis processor endorsement;
2.12(2) purchase hemp plant parts from industrial hemp growers;
2.13(3) make cannabis concentrate from medical cannabis flower;
2.14(4) make hemp concentrate, including hemp concentrate with a delta-9
2.15tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
2.16(5) manufacture medical cannabinoid products;
2.17(6) package and label medical cannabinoid products for sale to cannabis businesses with
2.18a medical cannabis processer endorsement or a medical cannabis retailer endorsement; and
2.19(7) perform other actions approved by the office.
2.20(f) The office must issue a medical cannabis retailer endorsement to a cannabis license
2.21holder if the license holder:
2.22(1) submits a medical cannabis retail endorsement application to the office;
2.23(2) deleted text begin has at least one employee who earned deleted text end new text begin identifies new text end a medical cannabis consultant new text begin who new text end
2.24 new text begin has a new text end certificate issued by the office and has completed the required training or deleted text begin has at least deleted text end
2.25 deleted text begin one employee who deleted text end is a licensed pharmacist under chapter 151 new text begin who the license holder employs new text end
2.26 new text begin or contracts with to consult and provide final authorization for a person enrolled in the new text end
2.27 new text begin registry program new text end ; and
2.28(3) otherwise meets all applicable requirements established by the office.
2.29(g) A medical cannabis retail endorsement entitles the license holder to purchase medical
2.30cannabis flower and medical cannabinoid products from cannabis businesses with medical
3.1cannabis cultivator endorsements and medical cannabis processor endorsements, and sell
3.2or distribute medical cannabis flower, medical cannabinoid products, and associated
3.3paraphernalia to any person authorized to receive medical cannabis flower or medical
3.4cannabinoid products.
3.5(h) A medical cannabis business with a medical cannabis retail endorsement must verify
3.6that all medical cannabis flower and medical cannabinoid products have passed safety,
3.7potency, and consistency testing at a cannabis testing facility approved by the office for the
3.8testing of medical cannabis flower and medical cannabinoid products before the cannabis
3.9business with a medical cannabis retail endorsement may distribute the medical cannabis
3.10flower or medical cannabinoid product to any person enrolled in the registry program.
3.11Sec. 2. Minnesota Statutes 2025 Supplement, section 342.51, subdivision 2, is amended
3.12to read:
3.13Subd. 2. Distribution requirements. (a) Prior to distribution of medical cannabis flower
3.14or medical cannabinoid products to a person enrolled in the registry program, an employee
3.15of a cannabis business must:
3.16(1) review and confirm the patient's enrollment in the registry program;
3.17(2) verify that the person requesting the distribution of medical cannabis flower or
3.18medical cannabinoid products is the patient, the patient's registered designated caregiver,
3.19or the patient's parent, legal guardian, or spouse using the procedures established by the
3.20office;
3.21(3) confirm that the patient had a consultation with (i) deleted text begin an employee with a valid deleted text end new text begin a new text end medical
3.22cannabis consultant new text begin who has a valid new text end certificate issued by the office; or (ii) deleted text begin an employee who deleted text end
3.23 deleted text begin is deleted text end a licensed pharmacist under chapter 151 to determine the proper medical cannabis flower
3.24or medical cannabinoid product, dosage, and paraphernalia for the patient if required under
3.25subdivision 3;
3.26(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
3.27product that includes recommended dosage requirements and other information as required
3.28by the office; and
3.29(5) provide the patient with any other information required by the office.
3.30(b) A cannabis business with a medical cannabis retail endorsement may not deliver
3.31medical cannabis flower or medical cannabinoid products to a person enrolled in the registry
3.32program unless the cannabis business with a medical cannabis retail endorsement also holds
4.1a cannabis delivery service license. The delivery of medical cannabis flower and medical
4.2cannabinoid products are subject to the provisions of section 342.42.
4.3Sec. 3. Minnesota Statutes 2024, section 342.51, subdivision 3, is amended to read:
4.4Subd. 3. Final approval for distribution of medical cannabis flower and medical
4.5cannabinoid products. (a) deleted text begin A cannabis worker who is employed by a cannabis business deleted text end
4.6 deleted text begin with a medical cannabis retail endorsement who is licensed as a pharmacist pursuant to deleted text end
4.7 deleted text begin chapter 151 or certified as a medical cannabis consultant by the office is the only person deleted text end
4.8 deleted text begin who may give deleted text end Final approval for the distribution of medical cannabis flower and medical
4.9cannabinoid products deleted text begin . Prior to the distribution of medical cannabis flower or medical deleted text end
4.10 deleted text begin cannabinoid products, a pharmacist or certified medical cannabis consultant employed by deleted text end
4.11 deleted text begin the cannabis business with a medical cannabis retail endorsement must consult deleted text end new text begin may only new text end
4.12 new text begin be given by a licensed pharmacist under chapter 151 or a medical cannabis consultant who new text end
4.13 new text begin has a certificate issued by the office after consultation new text end with the patient to determine the
4.14proper type of medical cannabis flower, medical cannabinoid product, or medical cannabis
4.15paraphernalia, and the proper dosage for the patient after reviewing the range of chemical
4.16compositions of medical cannabis flower or medical cannabinoid product intended for
4.17distribution:
4.18(1) if the patient is purchasing the medical cannabis flower or medical cannabinoid
4.19product for the first time;
4.20(2) if the patient purchases medical cannabis flower or a medical cannabinoid product
4.21that the patient must administer using a different method than the patient's previous method
4.22of administration;
4.23(3) if the patient purchases medical cannabis flower or a medical cannabinoid product
4.24with a cannabinoid concentration of at least double the patient's prior dosage; or
4.25(4) upon the request of the patient.
4.26(b) For purposes of this subdivision, a consultation may be conducted remotely by secure
4.27videoconference, telephone, or other remote means, as long as:
4.28(1) the pharmacist or consultant engaging in the consultation is able to confirm the
4.29identity of the patient; and
4.30(2) the consultation adheres to patient privacy requirements that apply to health care
4.31services delivered through telemedicine.

Bill information comes from public records published by the Office of the Revisor of Statutes, the Minnesota House and the Minnesota Senate. AI summaries are written by MinneSlate and are not official. MinneSlate is independent and is not affiliated with the State of Minnesota or the Minnesota Legislature.

Progress through the legislative process

17%
In Committee
Loading…